Cardiac development arises from two sources of mesoderm progenitors, the first heart field (FHF) and the second (SHF). Mesp1 has been proposed to mark the most primitive multipotent cardiac progenitors common for both heart fields. Here, using clonal analysis of the earliest prospective cardiovascular progenitors in a temporally controlled manner during early gastrulation, we found that Mesp1 progenitors consist of two temporally distinct pools of progenitors restricted to either the FHF or the SHF. FHF progenitors were unipotent, whereas SHF progenitors were either unipotent or bipotent. Microarray and single-cell PCR with reverse transcription analysis of Mesp1 progenitors revealed the existence of molecularly distinct populations of Mesp1 progenitors, consistent with their lineage and regional contribution. Together, these results provide evidence that heart development arises from distinct populations of unipotent and bipotent cardiac progenitors that independently express Mesp1 at different time points during their specification, revealing that the regional segregation and lineage restriction of cardiac progenitors occur very early during gastrulation.
The mammalian heart is the first functional organ that forms during embryonic development and is composed of cardiomyocytes (CMs), endothelial cells (ECs), epicardial derived cells (EPDCs) and smooth muscle cells 1 (SMCs). Cardiac development arises from two sources of mesoderm progenitors, the first heart field (FHF) and the second heart field 2,3 (SHF). Retrospective clonal analysis suggests the existence of a common progenitor for both heart fields, although the timing of the lineage segregation remains unclear 3 . Mesp1 is the earliest known marker of cardiac progenitors 4, 5 . Overexpression of Mesp1 in embryonic stem cells [6] [7] [8] [9] (ESCs) suggests that Mesp1 promotes the specification of the most primitive multipotent cardiac progenitors 7 . Lineage tracing using Mesp1-Cre knock-in mice showed also that almost all myocardial cells, including derivatives of the FHF and SHF, derive from Mesp1-expressing progenitors 4 . However, lineage tracing using Mesp1-Cre at the population level does not allow the assessment of whether FHF and SHF progenitors arise from a common progenitor or whether Mesp1 is expressed independently in distinct cardiac progenitors. To identify the developmental origin of organ regionalization and the timing of lineage segregation, it is essential to perform temporal clonal labelling in prospective progenitors 10 .
One of the key questions in mammalian development is the timing with which the progenitor becomes specified to differentiate into their different lineages. During chick heart development, it has been initially proposed that cardiac and vascular lineage could be already pre-specified at the early stage of gastrulation 11, 12 . In contrast, subsequent genetic lineage tracing in vivo and clonal differentiation of cardiovascular progenitors in vitro support the notion that, during mouse embryonic development, cardiovascular progenitors remain multipotent until the later stages of cardiogenesis at the time where they begin to express transcription factors such as Nkx2-5 and Isl1 (refs 6,7,13-15) . So far, no study has assessed the fate of prospective mouse cardiovascular progenitors into the different cardiovascular lineages using single-cell marking in vivo.
RESULTS

Doxycycline-inducible Mesp1 reporter and Cre -mediated recombination
To assess the contribution of single Mesp1-expressing progenitors at different time points during embryonic development, we generated a tetracycline-inducible Mesp1-rtTA transgenic mouse, in which 
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+Dox ----+ -+ - (d-g) Confocal analysis of Mesp1-Cre/Rosa-tdTomato heart sections at E14.5 co-stained with epicardial (Wt1; d), EC (endoglin; e), pace-maker (Hcn4; f) and SMC (smMHC; g) markers. lu: lumen. Scale bars, 20 µm.
(h) Scheme of the genetic strategy used for the characterization of the Mesp1-rtTA transgenic mice. Dox administration leads to the activation of the Cre recombinase between E6.25 and E7.5 in Mesp1-rtTA/TetOCre/Rosa-tdTomato embryos but no activation of the Cre recombinase was detected when Dox was administrated later (E8.5). Scale bars, 500 µm.
(i,j) Confocal analysis of Rosa-tdTomato (i) and Mesp1-rtTA/TetO-Cre/RosatdTomato heart sections (j) at E14.5 co-stained with anti-cardiac troponin T (cTnT). (k-n) Confocal analysis of Mesp1-rtTA/TetO-Cre/Rosa-tdTomato heart sections at E14.5 co-stained with epicardial (Wt1; k), EC (endoglin; l), pace-maker (Hcn4; m) and SMC (smMHC; n) markers. SAN: sino-atrial node. Scale bars, 20 µm. (o) Temporal analysis of the activation of the Mesp1-rtTA transgene. Whereas GFP expression was not induced in embryos in the absence of Dox, GFP + cells could be detected only 5 h after Dox injection in the primitive streak (PS) and nascent mesoderm. Scale bars, 100 µm. A: anterior, P: posterior. (p) Temporal analysis of the recombination of the RosatdTomato locus investigated by PCR following Dox administration. The RosatdTomato locus was recombined as soon as 6 h following Dox administration in Mesp1-rtTA/TetO-Cre/Rosa-tdTomato embryos at E6.25 and E7.25, as found with Mesp1-Cre/Rosa-tdTomato embryos at the same time points. Negative controls including WT tail and Rosa-tdTomato tail show PCR amplification corresponding to the unrecombined Rosa-tdTomato locus (around 1,000 bp) and Mesp1-Cre/Rosa-tdTomato hearts at E12.5 (positive control) show the recombined Rosa-tdTomato locus (about 180 bp).
the doxycycline (Dox)-dependent transactivator (Mesp1-rtTA) is expressed under the control of a fragment of the Mesp1 promoter expressed in cardiac progenitors during mouse embryonic development and ESC differentiation 7, 16 ( Fig. 1 ). We identified 6 Mesp1-rtTA founders that produce embryos with faithful expression of tdTomato in the heart when Dox was administrated to Mesp1-rtTA/TetO-Cre/Rosa-tdTomato embryos between embryonic day (E)6.25 and E7.5, corresponding to the timing of endogenous Mesp1 expression 4, 17 . The expression of the tdTomato was similar to that found in the Mesp1-Cre/Rosa-tdTomato embryos (Fig. 1a,h ), indicating that the Mesp1-rtTA transgene targets the same cells as in Mesp1-Cre knock-in. Dox administration during the later stage of cardiac development in Mesp1-rtTA/TetO-Cre/Rosa-tdTomato embryos after E8.0 did not induce Mesp1-rtTA/TetO-Cre/RosatdTomato expression, consistent with the transient expression of Mesp1 during the early step of cardiovascular progenitor specification 4 ( Fig. 1h) . Finally, Dox administration to Mesp1-rtTA/TetO-Cre/RosatdTomato embryos leads to the same labelling of all cardiovascular cell types of the FHF and SHF such as CMs, conduction cells, endocardial cells and EPDCs (Fig. 1a-n) , with the exception of some unlabelled SMCs in the SHF deriving from the neural crest 18 ( Supplementary Fig. 1a,b) .
To assess the temporal activation of the Mesp1-rtTA transgene on Dox administration, we administrated Dox to Mesp1-rtTA/TetO-H2B-GFP mice at E6.25, when Mesp1 begins to be expressed 4, 17 . Already at 5 h following Dox administration, H2B-GFP was detectable in the primitive streak and the nascent cardiac mesoderm (Fig. 1o) , in a similar pattern to that previously reported for Mesp1-LacZ knock-in mice 4, 17 . In situ hybridization revealed that Mesp1 and Cre were expressed at the same location in Mesp1-Cre knock-in and Mesp1-rtTA/TetO-Cre embryos treated with Dox ( Supplementary Fig. 1f-h ). PCR analysis showed that the Rosa-tdTomato locus was recombined, as early as 6 h following Dox administration at E6.25 and E7.25, similar to the case for Mesp1-Cre knock-in embryos (Fig. 1p) . All of these experiments indicate that Dox administration to Mesp1-rtTA/TetO-Cre embryos targets cardiovascular progenitors of both heart fields and faithfully recapitulates Mesp1-Cre knock-in mice.
Two temporally distinct populations of Mesp1 progenitors contribute to the FHF and SHF development
To investigate the contribution of a single Mesp1-expressing cell, we titrated the dose of Dox required to label Mesp1-rtTA/TetO-Cre/RosaConfetti hearts at clonal density, as defined by the dose of Dox allowing the recombination of a single fluorescent protein per heart and found that 0.575 µg g −1 of Dox was the lowest dose that could be used to induce the labelling of cardiac progenitors from E6.25 to E7.25 ( Supplementary Fig. 2a) .
To assess whether a single Mesp1 cell could mark a common progenitor of both heart fields, we administrated this lowest dose of Dox between E6.25 and E7.25, and analysed the contribution of labelled clones to heart morphogenesis at E12.5 (Fig. 2a,b) , when the segregation between the FHF and SHF derivatives is clearly established 3, 19 . From the ensemble of labelled hearts, 22% (37 out of 161) were unicolour, possibly arising from a single recombination event. However, in these unicolour hearts resulting from very low Cre activity, the frequencies of different colours were not equal: YFP and RFP were over-represented as compared with the CFP and nuclear GFP (Fig. 2c) , with the latter almost not expressed at all, as previously reported 20 . Unicolour hearts collected at E8.5 contained no more than 12 labelled cells, identifiable as a cluster of unicolour-labelled cells in the heart tube ( Fig. 2d,e) , which were not always cohesive (Fig. 2e) . These data support the idea that Mesp1-derived progenitors minimally expand from their specification in the primitive streak to the initial stage of heart tube development and may undergo a certain degree of cellular dispersion or fragmentation. Interestingly, by E12.5, most of the single-colour hearts contained more than one cluster of labelled cells with a mean of about 3 clusters per heart (2.5 clusters ± 0.37) suggesting that clones derived from Mesp1-derived progenitors may become separated into more than one fragment (Fig. 2f,g ), so that the total number of labelled patches represents the combined result of multiple cell induction and clonal fragmentation (Supplementary Note).
To functionally categorize with high fidelity the relative contribution of Mesp1-expressing cells to the FHF and SHF lineages, we defined as FHF derivatives embryos in which the left ventricle was labelled, and as SHF derivatives hearts in which the outflow tract and inflow tract were labelled 3, 21 . Out of 27 unicolour hearts analysed at E12.5, no unicolour clones were found to be present in both heart fields ( Fig. 2f-k) . Only 2 out of 27 unicolour hearts could not be classified into FHF or SHF, as they presented clones located only in the atria or the right ventricle, which are believed to derive from both heart fields 3, 19 (Fig. 2k) . As the clonal dose of Dox did not induce heart labelling when administrated at E5.75 ( Supplementary Fig. 2 ), we administrated a dose of Dox 40 times higher to investigate whether Dox administration before E6.25 can target early multipotent Mesp1-expressing cells that would escape our clonal analysis. This early induction marked cells that were exclusively distributed in the FHF ( Supplementary Fig. 2 ), ruling out the possibility that early Mesp1-expressing cells common for both heart fields were missed in our clonal tracing. Dox administration at the earliest time point of cardiac progenitor specification resulted in the preferential labelling of the left ventricle (6 out of 7 hearts at E6.25 and 6 out of 7 hearts at E6.75; Fig. 2h ,i,k,l), consistent with the initial emergence of Mesp1-derived FHF progenitors. In contrast, Dox administration at a later time point (E7.25) induced a preferential labelling of SHF derivatives (10 out of 13 hearts; Fig. 2j-l) , indicating that these two pools of cardiac progenitors are specified at different time points during development.
Bio-statistical modelling of the multicolour-labelled hearts to infer clonal fragmentation and multi-regional contribution of single Mesp1-expressing cells Although this observation strongly suggests that Mesp1 progenitors are already restricted to the FHF or SHF, to define the degree of clonal fragmentation, the regional contribution of the distinct progenitor pools, and the timing of their specification, we turned to a more rigorous statistical analysis based on the full range of clonal data including multicolour hearts (Fig. 3a,b ). Although cell labelling and clonal fragmentation occur in a stochastic manner (Fig. 3c) , the relative induction frequency, pN (the probability of induction of an individual Mesp1-expressing cell times the total number of cardiac precursors), and the clonal fragmentation rate, f , could be inferred from the total ensemble of labelled hearts (161 labelled hearts translating to n = 263 independent hearts by colour) using statistical inference ( Fig. 3d and Supplementary Note). By comparing the relative frequency of bicolour and tricolour hearts, we could infer the induction frequency, pN = 1.3 ± 0.05, independent of the clone fragmentation rate. Then, by fitting the distribution of fragment numbers to a model based on stochastic fragmentation ( Fig. 3e and Supplementary Fig. 3a,b) , we found a fragmentation rate of f = 1.6 ± 0.2.
With the known fragmentation rate f and induction frequency pN , we could then assess with a defined level of confidence which of the labelled hearts of any given colour are likely to derive from a single induced cell. In particular, we found that hearts with 3 fragments or less of a given colour were likely to be monoclonal (Fig. 3f , examples in Fig. 3g ,h, Supplementary Table 1 and Supplementary Note). Following this classification, we identified 89 clones in our collection of multicolour hearts that were likely to be of monoclonal origin. Remarkably, we found that all of the clones that contained fragments in the FHF or SHF were restricted to one or the other heart field, confirming that the FHF and SHF progenitors arise from distinct Mesp1 progenitors. In contrast, of the 69 clones that had fragments in the FHF, 15% also have fragments in the other heart compartments. Similarly, of the 20 clones that have fragments in the SHF, 55% have fragments in other heart compartments ( Fig. 3i and Supplementary Table 1 ), demonstrating that once heart progenitors have been specified, they are likely to undergo clonal fragmentation that will contribute to the morphogenesis of distinct heart regions, consistent with the regions associated with the FHF and the SHF obtained by retrospective clonal analysis 3 . By assessing the proportion of FHF and SHF precursors that are labelled at each induction time, we found that most FHF derivatives were induced from E6.25 to E6.75 whereas most SHF derivatives were labelled between E6.75 and E7.25 (Fig. 3j) . Finally, by computing pN and f for each heart field separately, we found that f = 1.4 ± 0.2 for the FHF whereas f = 1.9 ± 0.3 for the SHF, showing that the latter undergoes a slightly higher rate of fragmentation ( Supplementary  Fig. 3c ). Together, these results indicate that Mesp1-expressing cardiac With an induction frequency pN = 1.3, and the fragmentation rate f = 1.6, the statistical model (solid line) is in excellent agreement with the experimental data. n = 263 hearts by colour. (f) Statistical analysis allows restriction of the analysis to fragments that are likely to be monoclonal with a known error rate of 12% ( Supplementary Fig. 5c and Supplementary Note). (g,h) Examples of E12.5 multicolour hearts induced at E6.25 (g) or E7.25 (h). Scale bars, 200 µm. In the right corner is indicated which colour is considered as clonal, based on the statistical analysis. We compare the probability L(m = 1|k) that k fragments stem from a single clone (black line) with the probability L(m > 1|k) that these fragments stem from more than one cell (solid blue line). The latter is given by the sum contributions of clones with multiple cell origins (dashed blue lines). We consider k fragments as monoclonal if progenitors consist of two temporally distinct populations that sequentially contribute to FHF and SHF development.
Mesp1 lineage is not exclusive to the heart but also marks other mesodermal lineages such as head muscles 22, 23 . Retrospective clonal analysis has suggested a common origin for the head muscles and myocardium derived from the SHF (ref. 24) . Interestingly, 11% of the embryos analysed showed co-labelling of the head muscles and the heart with the same colour ( Supplementary Fig. 4a,b) . The labelling of the head muscles was preferentially observed at the late induction time and was associated with the labelling of SHF derivatives including the RV ( Supplementary Fig. 4c,d ). These results indicate that common progenitors for head muscles and heart myocardium encompass the pool of Mesp1 progenitors contributing to the SHF, consistent with previous retrospective clonal analysis 24 .
A R T I C L E S
Mesp1 progenitors consist of unipotent and bipotent progenitors
Until now, most studies assessing the differentiation potential of cardiac progenitor cells at the clonal level have been performed in vitro, and therefore may lack some important extrinsic cues that cardiac progenitors encounter during their in vivo specification.
In vitro differentiation of single fluorescence-activated cell sorting (FACS)-isolated early cardiac progenitors (Mesp1-GFP or Brachyury-GFP/Flk1) from mouse embryos and during ESC differentiation shows that these early cardiac progenitors differentiate into CMs, ECs and SMCs, a fraction of which are multipotent at the clonal level 7, 15 . Likewise, later born Nkx2-5/cKit + cardiac progenitors cells, which are preferentially enriched for FHF progenitors, differentiate into CMs, SMCs or both 13 , whereas Isl1/Flk1 + cells, which are preferentially enriched for SHF progenitors, give rise to colonies that differentiate into CMs, SMCs and ECs at the clonal level in vitro 14 . Conflicting results have been obtained concerning the fate of cardiac progenitors in vivo during vertebrate development 25 . Dye-and retroviral-based tracing analyses during chick heart morphogenesis suggest that CMs and ECs arise from distinct pools of progenitors 11, 12 , whereas lineage tracing in mouse embryos showed that these progenitors can differentiate into myocardial cells, SMCs and ECs at the population level 14, 26, 27 , supporting the notion that during mouse development, cardiac progenitors are multipotent 25 . However, the constitutive activity of the Cre expressed in the cardiac cells precludes assessment at the clonal level as to whether the different cell types (CMs, SMCs and ECs) arise from multipotent or distinct unipotent progenitors.
To assess the fate of single Mesp1-expressing progenitors during cardiovascular development in vivo, we assessed the coexpression of fluorescent proteins with specific markers of the different cardiovascular cell types in clonally induced Mesp1-rtTA/TetO-Cre/Rosa-Confetti embryos. We analysed hearts expressing fluorescently labelled patches at E12.5 and assessed the fate of the Mesp1 + labelled cells on serial sections in a given unicolour patch ( Fig. 4a-i) . Surprisingly, all Mesp1-derived clones found in the left ventricle and in the atria were differentiated into either CMs or ECs ( Fig. 4c-g ). The unipotent Mesp1-derived CM progenitors are likely to give rise to the recently identified HCN4
+ unipotent FHF CM progenitors that are identified later during cardiac development 28, 29 . Whereas the clones of CMs in the ventricles remain relatively cohesive, the clones of ECs composing the endocardium were not cohesive and were intermingled with many unlabelled ECs ( Supplementary Fig. 5 ). In contrast, although some of the Mesp1 progenitors of the SHF were also unipotent, differentiating into either CM or ECs, as previously reported during avian heart development 11, 12, 30 , Mesp1 progenitors of the SHF can also be bipotent, especially in the outflow or inflow tract regions (85% of the bipotent clones), differentiating into CMs and ECs (Fig. 4c ,h-h'), or CMs and SMCs (Fig. 4c ,i-i') at the clonal level.
Finally, we assessed the developmental origin and fate of the progenitors of the epicardium, the envelope that surrounds the heart, which give rise to the cardiac fibroblasts and SMCs of the coronary arteries 31 . The developmental origin of the epicardium in respect to the other cardiovascular progenitors remains unclear [32] [33] [34] . Our Mesp1 clonal analysis revealed that 13 out of 37 unicolour induced hearts showed labelling in the epicardium (Fig. 4j-l) , mostly arising following Dox administration at the earliest time of Mesp1 progenitor specification (Fig. 4j) . Ten of the thirteen epicardium unicolourlabelled hearts (77%) showed only contribution to the epicardium (Fig. 4k) , and 3 out of 13 hearts (23%) were also associated with labelled CMs (Fig. 4l) , suggesting that most epicardial cells arise from an independent population of unipotent Mesp1 progenitors that will give rise to the epicardium lineage, and a small fraction of Mesp1 progenitors may be bipotent, giving rise to CMs and EPDCs.
The molecular heterogeneity of Mesp1 progenitors reflects their regional and lineage-restricted contribution
To gain further insights into the molecular mechanisms that control Mesp1 progenitor specification and lineage segregation during the early stage of cardiac mesoderm formation, we performed transcriptional profiling of Mesp1-expressing cells during the early and late stage of Mesp1 progenitors. To this end, we administrated Dox to Mesp1-rtTA/TetO-H2B-GFP embryos at E6.25, or E7.25, isolated Mesp1 H2B-GFP + and H2B-GFP − cells by FACS 6 h later, and performed microarray analysis in two independent biological experiments ( Fig. 5a ). At E6.5, Mesp1 was the sixth most upregulated probe out of 46,000 probes, further demonstrating that our transgenic approach faithfully marked Mesp1-expressing cells. Interestingly, the comparison of these Mesp1 in vivo arrays to previous published arrays performed following Mesp1 overexpression or Mesp1-GFP + cells during ESC differentiation 6, 7 ( Fig. 5b) showed an important overlap between the genes differentially regulated in the Mesp1 GFP + cells at E6.5 and the genes regulated by Mesp1 gain of function in ESCs or associated with Mesp1-GFP at day 3 of ESC differentiation (Supplementary Table 2 and 3) . Gene Ontology analysis revealed that Mesp1 progenitors at E6.5 are statistically highly enriched in genes regulating embryonic patterning and regionalization, heart and blood vessel morphogenesis, and transcriptional regulation (Fig. 5c ). These genes comprised many key transcriptional factors known to act upstream of Mesp1 (for example, Eomes, T ; refs 35,36), downstream of Mesp1 or co-regulated with Mesp1 and regulating EMT (for example, Snail1) or controlling cardiovascular development (for example, Gata4, Gata6, Hand1, Meis2; refs 6,8,9; Fig. 5d and Supplementary Table 2 ). Many genes controlling key developmental signalling pathways, such as Wnt, Notch, BMP, TGF-b, FGF pathways that are regulated by Mesp1 in vitro [6] [7] [8] , were also preferentially expressed in Mesp1-expressing cells in vivo (Supplementary Table 2 ). Also Mesp1-expressing cells preferentially expressed genes associated with cell polarity and migration (for example, Fn, Cdh11, N-cadh, Wnt5a, Vangl1, Ninein; Supplementary Table 2) , consistent with the role of Mesp1 in regulating cardiac progenitor migration 4, 37 . Flk1 and Pdgfra, two genes encoding cell surface markers previously shown to mark Mesp1-expressing cardiovascular progenitors during mouse and human ESC and induced pluripotent stem cell differentiation 6, 15 , were also upregulated in Mesp1-GFP in vivo (Fig. 5e-i) , and the same combination of cell surface markers (Flk1, Pdgfra and CXCR4) could be used to greatly enrich early Mesp1 progenitors during embryonic development in vivo (Fig. 5j) . Comparison between Mesp1-GFP + cells at E6.5 and E7.5 revealed that Mesp1 progenitors share very similar expression profiles with several Mesp1 direct target genes, such that Gata4, Gata6 and Aplnr were upregulated in Mesp1 + cells at the early and late time points (Fig. 5k) . Despite these similarities, early and late Mesp1-expressing cells present also important molecular differences including the differential expression of transcription factors and Hox-related genes, previously identified in controlling pattern and , suggesting that these genes may regulate the patterning of the primitive streak (Supplementary  Table 2 44) were preferentially expressed in the early Mesp1 cells (Fig. 5k,l) , whereas many genes known to be associated with or controlling the morphogenesis of the SHF, such as Aldh1a2 (ref. (Fig. 5k,m) . (Fig. 6a-h ), on single FACS-isolated Mesp1 H2B-GFP + cells at E6.5 and E7.25 (Fig. 6i ,j and Supplementary Fig. 6 ). Interestingly, not all direct Mesp1 target genes are expressed in every Mesp1 + cells at the same time. Snail1 is the most commonly Mesp1 co-expressed gene irrespective of the embryonic stages (n = 75), followed by Gata6, Gata4 and Aplnr (Fig. 6i,j) . Interestingly, at E6.5, less than 10% of Mesp1 cells expressed Mesp1 target genes associated with SHF (Hoxb1 and Foxc2; refs 48,53; Fig. 6i) . However, at E7.5, the number of Mesp1 cells expressing SHF markers increased by tenfold, with 20-30% of cells expressing either Hoxb1 or Foxc2 (Fig. 6j) . The analysis of the expression of Myl7, a marker of CMs (ref. 54), and Etv2, a transcription factor associated with endothelial and endocardial cell fate [55] [56] [57] [58] , revealed that at E6.5, Mesp1 cells usually expressed either Myl7 or Etv2, whereas at later stages more Mesp1-expressing cells co-expressed these 2 markers (Fig. 6j) , consistent with the early unipotent FHF and the late bipotent SHF progenitors found in our clonal analysis. These single-cell transcriptional profiling analyses of Mesp1 progenitors support the existence of molecularly distinct populations of Mesp1 progenitors, reflecting their different regional and lineage contribution.
DISCUSSION
In contrast to the current model of cardiovascular development, in which Mesp1 is thought to mark the most primitive multipotent cardiovascular progenitors common to the FHF and SHF, our temporal clonal analysis of Mesp1-expressing cells provides compelling evidence that Mesp1 marks distinct classes of cardiovascular progenitors with restricted lineage differentiation at different time points during gastrulation (Fig. 7) . The absence of common FHF and SHF progenitors among Mesp1-expressing cells suggests that the common progenitor identified in retrospective clonal analysis 3 exists before gastrulation in the epiblast cells expressing Eomes, a transcription factor that directly controls Mesp1 expression 35, 36 . Our prospective clonal analysis of heart development reveals that, unexpectedly, most Mesp1-derived cardiovascular progenitors of the Figure 7 Revised model of the early step of cardiovascular progenitor specification and lineage commitment during mouse development. Clonal and molecular analysis of Mesp1 progenitors shows the existence of temporally distinct Mesp1 progenitors that contribute to the heart development. FHF are restricted to either CM or EC cell fates at the time of their specification. In contrast, Mesp1-derived SHF progenitors can be unipotent or bipotent (Fig. 7) . The main difference between the multilineage differentiation potential of cardiovascular progenitors in vitro 6, [13] [14] [15] 59 and their more restricted fate in vivo suggests that the ultimate fate of the progenitors can be regulated by the environmental cues that the different progenitors encounter during cardiac morphogenesis.
Our molecular analysis of Mesp1 progenitors provides the first transcriptional profiling of the early cardiac progenitors in vivo and uncovered that the two populations of Mesp1 progenitors, although very similar molecularly, present also notable differences, consistent with their lineage and regional contribution. This analysis identified several key markers, such as Mixl1, Otx1 and Evx1, that are preferentially expressed in the early Mesp1 cells, whereas Aldh1a2, RXRa, Foxh1, Foxc1/Foxc2, Hoxa1, Hoxb1, and Hoxb2, Smarcd3, all genes known to be expressed during or controlling SHF morphogenesis [45] [46] [47] [48] [49] 53 , are preferentially expressed in the late Mesp1 progenitors. Further studies will be required to define which of these differentially regulated genes temporally and spatially control the emergence of the distinct populations of Mesp1 progenitors during gastrulation. Whereas previous studies proposed that Mesp1 acts as a master regulator of cardiovascular development 6, 8, 9 , our single-cell RT-PCR analysis demonstrates that Mesp1 only induces the expression of a combination of different direct target genes in different cells. Understanding how this specificity is achieved will be important to instruct and/or restrict the fate of multipotent cardiovascular progenitors into a particular cell lineage in vivo. The answers to these questions will be important both to design strategies to direct the differentiation of cardiovascular progenitors derived from ESCs and induced pluripotent stem cells specifically into pure populations of CMs, and for improving cellular therapy in cardiac diseases.
METHODS
Methods and any associated references are available in the online version of the paper. Generation of Mesp1-rtTA mice. The coding sequence of the rtTA (Clonetech)
was subcloned under the control of a 5.6 kb fragment of the Mesp1 promoter previously shown to be active in cardiac progenitors in vivo 16 and during ESC differentiation in vitro 7 . The Mesp1-rtTA fragment was linearized and microinjected into fertilized oocytes by Y. Achouri from the transgenic core facility of the Université Catholique de Louvain (UCL). Transgenic founders were identified by PCR and their functional characterizations were confirmed by lineage tracing experiments using Mesp1-rtTA/TetO-Cre/Rosa-tdTomato following doxycycline (Dox) administration (25 µg g −1 of Dox injected at embryonic day (E)6.25 by intravenous injection followed by Dox administration in the drinking water (2 mg ml −1 ) until E7.5).
The induction was also assessed in Mesp1-rtTA/TetO-H2B-GFP embryos after intravenous injection of 25 µg g −1 of Dox at E6.25. After 5 h, GFP was detected and embryos were imaged with a macroscope (Axiozoom V16, with an Axiocam MRN camera, Carl Zeiss) and the Zen Blue software (Carl Zeiss).
Assessment of the recombination of the Rosa-tdTomato reporter by PCR.
Genomic DNA was extracted by DNA precipitation with ethanol from the tail of an adult wild-type mouse, from an adult Rosa-tdTomato (control for no recombination) mouse or from the heart of an E12.5 Mesp1-Cre/Rosa-tdTomato (control for recombination) mouse. For E6.5 and E7.5 Mesp1-Cre/Rosa-tdTomato and Mesp1-rtTA/TetO-Cre/Rosa-tdTomato embryos, the complete litter (n = 8 embryos) was lysed in 50 µl of lysis buffer (1× PCR-buffer (Qiagen), proteinase K (0.04 mg ml In situ hybridization. Embryos were extracted at E6.75 and fixed overnight in 4% paraformaldehyde and processed according to published protocols 63 with some modifications: the proteinase K treatment was performed at the concentration of 5 µg ml −1 and the hybridization was realized overnight at 68 • C in 5× SSC (pH 5), 50% formamide, 500 µg ml −1 yeast tRNA, 100 µg ml −1 heparin, 0.5% CHAPS and 0.2% Tween20. The hybridization signal was revealed by using NBT/BCIP (Roche) for Mesp1 antisense riboprobes or BM Purple (Roche) for Cre antisense riboprobes. Chromogenic substrate and embryos were acquired in 75% glycerol in PBST (0.1% Tween20) with a Leica MZ16F stereomicroscope (Leica Microsystems). Acquisition data were treated with LAS V4.2 software (Leica Microsystems, Belgium) and exported in TIF image format. In situ hybridization for Cre and Mesp1 was performed on at least 4 different litters for each genotype or condition.
Antisense riboprobes for Mesp1 (ref. Clonal analysis of Mesp1-expressing cells. Mesp1-rtTA/TetO-Cre mice were crossed with the Rosa-Confetti reporter mice. The day of plug identification corresponds to embryonic day E0.5. Doxycycline (Dox; Sigma; 0.575 µg g −1 or 25 µg g −1 ) was administered by intravenous injection at E5.75, E6.25, E6.75, E7.25 or E8.5. Embryos were collected at E8.5 or E12.5 and fixed in 4% paraformaldehyde for 30 min and 1 h and 30 min respectively. Fluorescent protein expression was analysed with a macroscope (Axiozoom V16, with an Axiocam MRN camera, Carl Zeiss) and the Zen Blue software (Carl Zeiss). Acquisitions were done with a ×1 PLAN APO Z ×1.0/0.25 objective. For each fluorescent protein, a z-stack was acquired and the algorithm 'extended depth of focus' was used to produce two-dimensional images and the data were then merged and exported in TIF image format.
Immunofluorescence analysis. Immunofluorescence was performed on frozen heart sections (Leica Cryostat-20 µm). Sections were stained in PBS with 1% BSA, 0.5% Triton and 5% horse serum. Sections were stained with the following primary antibodies: anti-cTnT (MS-295-P, mouse, clone 13-11; 1:100; Neomarkers, Fremont), anti-endoglin (AF1320, goat, 1:500, R&D), anti-smMHC (BT562, rabbit, 1:100, Biomedical Technologies), anti-Wt1 (Sc-192, rabbit, 1:100, Santa Cruz), anti-HCN4 (Ab32675, rat, 1/100, Abcam). Counterstaining of nuclei was performed with Hoechst (1/40,000). Acquisitions were acquired with a confocal microscope (LSM780; Carl Zeiss) with a ×20 Plan Neofluar objective (×20; 0.8 numerical aperture). Collection of sequential 0.22 µm-0.60 µm thicknesses, 1, 024 × 1, 024-pixel optical sections were acquired for each fluorescent protein. The acquisition data were then treated with Zen black software (Carl Zeiss) and exported in TIF image format. All experiments were reproduced in at least 3 biological samples.
Microarray analysis. For transcriptome analysis, Mesp1-rtTA/TetO-H2B-GFP embryos induced with 25 µg g −1 of Dox by intravenous injection at E6.25 or E7.25 were extracted 6 h after Dox administration and dissected in a dissection medium (DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS)). Embryos were selected for their expression of GFP with a macroscope (Axiozoom V16, with an Axiocam MRN camera, Carl Zeiss). Cells were dissociated for 3 min at 37 • C in trypsin/EDTA (tryspin 0.1%, EDTA 1 mM) and resuspended into PBS supplemented with 10% FBS and 1:1,000 of propidium iodide.
FACS analysis was performed using a FACSAria I at high pressure (70 p.s.i.) and FACSDiva software (BD Biosciences). Living (gated with propidium iodide dye exclusion) cells were sorted on the basis of the expression of GFP. We sorted 50 GFP + or GFP − cells at E6.5 or E7.5 and cells were collected directly in 45 µl of lysis buffer (20 mM dithiothreitol, 10 mM Tris-HCl pH 7.4, 0.5% SDS, 0.5 µg µl −1 proteinase K). Samples were then lysed at 65 • C for 15 min and frozen. RNA isolation, amplification and microarray were performed by A.R. and H.A. in the Functional Genomics Core, Barcelona. RNA was isolated using magnetic beads. cDNA synthesis, library preparation and amplification were performed as described previously 65 . Amplification was performed for 25 cycles. Subsequently, cDNA was purified on PCR GenElute Clean Up Kit (Sigma Aldrich) and eluted in 30 µl water. cDNA concentration was determined using the Nanodrop 1000 spectrophotometer. Microarrays were then performed on a Mouse Genome 430 PM strip Affymetrix array. The data were normalized using the RMA algorithm. The entire procedure was repeated in two biologically independent samples. Genetic signatures were obtained by considering genes presenting a fold change greater or smaller than 1.5 or −1.5, respectively.
The microarray data have been deposited in the Gene Expression Omnibus of NCBI and are accessible through GEO accession number GSE59033 (http://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59033).
Flow cytometry.
For flow cytometry analysis, Mesp1-rtTA/TetO-H2B-GFP embryos were induced with 25 µg g −1 of Dox by intravenous injection from E6.25 followed by Dox administration in the drinking water (2 mg ml −1 ) until E7.5. Embryos were extracted at E6.75, E7.25 or E7.75 dissected in a dissection medium (DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS)). Embryos were selected for their expression of GFP with a macroscope (Axiozoom V16, with an Axiocam MRN camera, Carl Zeiss) (n = 4/5 embryos per litter). Cells were dissociated for 3 min at 37 • C in trypsin/EDTA (tryspin 0.1%, EDTA 1 mM) and resuspended in PBS supplemented with 1% bovine serum albumin. Staining for Flk1, Pdgfra and Cxcr4 was performed as previously described 6 . Flk1 (VEGFR2) was stained for 30 min at room temperature using a biotinylated antibody at 1:100 (13-5821, clone Avas12a1; eBioscience) revealed by a streptavidinphosphatidylethanolamine (PE)-Cy7 secondary antibody at 1:400 (557598, BD). PDGFRa was stained using a PE-coupled rat monoclonal antibody at 1:75 (12-1401, clone APA5; eBioscience). CXCR4 was stained using an APC-coupled rat monoclonal antibody at 1:100 (17-9991, clone 2B11; eBioscience). Living cells were gated by Hoechst dye exclusion (1:3,000). FACS analyses were performed on a FACSFortessa device (BD) in duplicate biological samples.
qPCR on Mesp1-overexpressing ESCs. ESC culture, RNA extraction and qPCR analysis were performed as previously described 6 . Briefly, Dox-inducible Mesp1-Flag ESCs were cultured on irradiated mouse embryonic fibroblasts in ESC Medium (DMEM (Gibco) supplemented with 15% ESC-qualified FBS (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 0.1 mM β-mercaptoethanol (Sigma-Aldrich), 100 U ml −1 penicillin (Invitrogen), 100 µg ml −1 streptomycin (Invitrogen), and 1,000 U ml −1 leukaemia inhibitory factor (ESGRO)). ESC differentiation was performed in hanging drops of 1,000 cells in 25 µl ESC medium without LIF, supplemented with 50 µg ml −1 ascorbic acid (Sigma). Doxycycline (Dox, Sigma) was added to hanging drops at day 2 to a final concentration of 1 µg ml −1 . After 24 h post-induction of Dox, the embryoid bodies with or without Dox were collected for RT-qPCR. Total RNA and DNase treatments were performed according to the manufacturer's instruction (Absolutely RNA MiniPrep Kit, Stratagene). One microgram of total RNA was used for reverse transcription by using Superscript II (Invitrogen) with Oligo dT primer, and qPCR was performed by using Power SYBR Green Master Mix, (Invitrogen) on a realtime PCR system (Mx3005P; Agilent Technologies). qPCR primers were described in Supplementary Table 4 .
Mesp1 ChIP-Seq analysis on Mesp1-overexpression ESCs. Chromatin for chromatin immmunoprecipitation (ChIP) was obtained from Mesp1-overexpressing differentiating ESCs (ref. 6). Embryoid bodies (10 × 10 6 cells) were collected 36 h after the induction with Dox at day 2 of differentiation and fixed with 1% formaldehyde for 7 min. Formaldehyde was quenched with 0.125 M glycine for 5 min at room temperature. Embryoid bodies were lysed according to the manufacturer's instructions (ChIP-IT Express Kit, Active Motif) and crosslinked DNAs were sonicated during 2 cycles of 5 min (30 ON/30 OFF) with a Bioruptor Sonicator (Diagenode). Sheared DNAs have a size range between 100 and 300 bp. ChIP was performed by using anti-Flag-M5 antibody (F4042, Sigma) or the isotype control (M5284, Sigma) according to the manufacturer's instructions (ChIP-IT express kit, Active Motif). Total yields of DNA obtained after ChIP were purified by the Ipure kit (Diagenode). Libraries were prepared, generated and sequenced at the Genomic core facility (Heidelberg) using a 5X Illumina HiSeq sequencer.
ChIP-Seq reads, from Mesp1 or isotype control ChIP, were aligned to the UCSC mm9 version of the mouse genome using Bowtie 66 . Note that when a read could be aligned at more than one position, only one position (the top scoring) was kept.
Peak identification was performed by using MACS software 67 with standard parameters. The cutoff P value used is 1 × 10 −5 .
Single-cell RT-PCR analysis.
For single-cell analysis, Mesp1-rtTA/TetO-H2B-GFP embryos induced with 25 µg g −1 of Dox by intravenous injection at E6.25 or E7.0 were extracted 6 h after Dox administration and dissected in a dissection medium (DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS)). Cells were dissociated for 3 min at 37 • C in trypsin/EDTA (tryspin 0.1%, EDTA 1 mM) and resuspended in PBS supplemented with 10% FBS and 1:1,000 of propidium iodide.
FACS analysis was performed using a FACSAria I at high pressure (70 p.s.i.) and FACSDiva software (BD Biosciences). Living (gated with propidium iodide dye exclusion) cells were sorted in 96-well plates with the FACSDiva software (BD Biosciences) on the basis of the expression of GFP. We have single GFP + cells at E6.5 or E7.5 and cells were collected directly in 4.5 µl of single-cell firststrand buffer (Superscript III buffer, Invitrogen), 0.5% Nonidet P40 (Pierce), 10 mM dNTP mixture (Invitrogen), 42 pmol l −1 of the RT primer 68 , 1 mM dithiothreitol (Invitrogen), 10 mM dNTP mixture (Qiagen), SuperRNaseIN (Ambion), and RNAout (Invitrogen). After sorting, single cells were snap-frozen in liquid nitrogen and subsequently lysed at 65 • C for 5 min.
For single-cell PCR, generation of cDNA, and PCR amplification were performed as previously described 69, 70 with incorporation of suppression PCR (ref. 68) . In brief, after lysis RT primers (Supplementary Table 4 One sees that the maximum value of F is relatively featureless along a curve in the pN-f-plane. To infer the values of pN and f we must therefore refer to an independent measurement of one of the two parameters. b. The multicolour labelling strategy allows us to independently infer the induction frequency pN=1.3 by evaluating the abundances of hearts with a given number of colours. With this, we are left with a slice through the pN-f-plane and the fragmentation rate can be determined with a higher accuracy. c. Monoclonal datasets (n=89) identify two subpopulations in Mesp1 expressing cells: FHF progenitors, which contribute to the LV and SHF progenitors, which contribute to OFT and IFT. The plot shows the probabilities of monoclonal fragments in the different heart compartments. d. Values for the induction frequency, pN, and the fragmentation rate, f, for the two FHF (n=188) and SHF (n=102) precursors. While the overall induction frequency is higher for FHF precursors, which we attribute to highest expression of Mesp1 at the early time points, the fragmentation rate is higher for SHF precursors. e. We may use the distribution of monoclonal fragments (c) to predict the distribution of fragments in all hearts (n=263). We find an excellent agreement with the notable exception of the RV, which might suggest the existence of an independent pool of progenitors contributing to RV morphogenesis. Error bars indicate one sigma (c and e) or 95% (d) confidence intervals. combinations. Then, if there are a total of Mesp1 expressing progenitor cells at the time of induction, if the induction probability of each cell is considered statistically uncorrelated with its neighbors, the probability distribution for the number of induced cells for a given color is given by the binomial distribution,
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where the binomial coefficient is defined by
. Then, if the induction probability is clonal (i.e. is of the order of 1/ ), we can make a Poisson approximation,
In particular, the probability that the tissue remains completely unlabeled is given by !!" and, as expected, the mean number of induced cells is = .
Let us now consider the potential for Mesp1 cell--derived clones to undergo fragmentation.
Clone fragmentation
Once a precursor cell has been induced, in the course of its clonal expansion through cell proliferation, cells may disperse and the clone may fragment into multiple subclones. To account for this process of fragmentation, we may once again model these events as a statistically uncorrelated Poisson random process, so that the probability that an individual clone ends up in fragments (i.e. it undergoes − 1 fragmentations) is given by
where denotes the degree of fragmentation, defined as the average number of fragmentations experienced by a single cell--derived clone over the time course from induction to analysis. The degree of fragmentation represents the time--integral of the underlying fragmentation rate, which may itself vary over time. Of course, the degree of fragmentation may depend on the total size of the clone, i.e. large clones may fragment more than small clones. To investigate this, we calculated the surface area (SA) of clones in unicolor hearts, i.e. the percentage of the heart's surface clones cover ( = 18). We indeed found that clones vary significantly in SA at each induction time. However, comparing the size of these clones to the number of fragments did not show any significant correlation (Spearman's rank correlation, = 0.19, = 0.45). Therefore, since we will later see that most of these hearts are monoclonal, there is no evidence in the data that the degree of fragmentation depends on the size of clones.
With this definition, what then is the probability distribution of finding a total of labeled fragments if cells of a common color have been induced? In this case the number of fragmentation events is given by the total number of fragments minus the number of induced cells, − . Then, taking the fragmentation and induction events to be statistically independent, the branching probability, ( | ), is described by a Poisson process with an effective rate • , and
where ≥ . Therefore, with this result, we can infer the joint probability distribution for finding a heart with m induced cells giving rise to a total of fragments of a given color,
with ≥ . (Note that, as defined here, the number of fragments must obviously be bound by the number of induced cells.)
In practice, in any given experiment, only the total number of labeled fragments (of a given color) is accessible -the underlying number of induced cells (clones) cannot be recovered for any given cluster of fragments. Moreover, we only have access to the frequency of clone fragments when at least one cell has been induced. The frequency of non--induced hearts is not recorded. Therefore, we should exclude the contribution of = 0 from the statistical ensemble. In this case, the joint size distribution of "labeled" clones is therefore given by
where > 0. For these persisting clones, since we measure only clonal fragments, we should combine all possible induction outcomes, from which we obtain the persisting fragment distribution,
From this expression, we find that the average number of labeled fragments is given by
Hence, the average number of fragments in labeled hearts increases linearly with the degree of fragmentation f and, for moderately large values of , linearly with the induction frequency.
Fitting the data
Already at this point we may try to give an estimate on the values of and for the heart as a whole. For our analysis, we do not take into accounts hearts, which are labeled in a specific color in the epicardium. The reason for this choice is that the outer unicellular layer is formed by cell migration quite late compared to the induction time (at E9.5), leading to very dispersed cells across the epicardium. This makes it difficult to distinguish labeled cells in the epicardium from those in the IFT and OFT. Making use of the formula for and explicitly denoting its dependence on the parameters, we calculate the probability that the observed fragment numbers are found for any given degree of fragmentation, , and induction frequency, . As the observations ! , ! , … are statistically independent this probability is given by:
Treating as a function of and (which is then generally called the likelihood), we may now ask for the maximum of this likelihood function: the values of and that yield the experimental data with highest probability. We consider these values to be the best estimate for the degree of fragmentation and induction frequency. From this analysis, we find that = 1.7 ± 0.8 and = 1.3 ± 1.0 (95% confidence intervals). The large confidence intervals reflect the fact that the maximum of the likelihood function cannot be precisely determined along a curve in the ----plane (Supplementary Fig. S3a) . In other words, all of these parameters fit the experimental data equally well within the limits of statistical significance. In the following we therefore develop an independent approach to further constrain the two fitting parameters.
The multicolor labeling assay provides a means to independently infer the induction frequency,
. To understand how, consider first the probability that a heart remains unmarked in any one of the three colors following Dox administration (we do not consider the GFP+ contributions as the induction frequency of these cells is found to be negligibleonly one heart was found to contain any GFP+ cells. If the relative induction frequency of the three colors (YFP, RFP, and CFP) is equal, then this probability is given by 0,0 ! = !!!" . Therefore, the probability that an induced tissue involves all three colors (regardless of the number of fragments) is given by the probability that the tissue is clonally labeled in all three colors divided by the probability that the tissue is labeled at all:
Similarly, the chance that an induced tissue involves two out of three colors is given by
while those that involve only one color is set by,
Since these probabilities are independent of the fragmentation probability, , they can be used to provide an independent estimate of the induction frequency, .
To estimate the induction frequency of cells, we could immediately apply the results above to investigate the relative frequency of unicolor, bicolor and tricolor clones. However, in this case, we have to exercise some caution: Analysis of the unicolor clones shows that the induction frequency of the CFP is significantly smaller than the RFP and YFP with only 3 CFP+ clones out of a total of 23. By contrast, both the bicolor and tricolor hearts have a roughly equal representation of the three colors: In hearts which are labeled in any of the two heart fields, the multiplicity of RFP:YFP:CFP is 23:22:13 for bicolor and 55:57:66 for tricolor. While the multiplicity of colors is far from perfectly equal in the bicolor case, the comparison of the fitted distribution with the experimental data will further validate our approach. Then, since
we can use the ratio of the number of bicolor to tricolor clones to infer the induction probability, . With a measured ratio of 1.10, we find that = 1.31 ± 0.05. We performed the same calculations by explicitly taking the lower induction frequency of CFP in bicolor hearts into account. With this approach we obtain an average induction frequency, pN, of roughly 1.4 for all fluorescent markers in tricolor hearts and RFP and YFP in bicolor hearts, i.e. we find only a minor deviation for most observed hearts. The induction frequency of CFP in bicolor hearts involving CFP would correspondingly be about 0.7. Therefore, the pN value only changes significantly for CFP in bicolor hearts. As we will see below, this only marginally influences the outcome of the statistical analysis.
Therefore, on average, pooling all of the data from the three induction times, we expect that approximately 1.3 cells are induced per color in each heart. However, this estimate includes hearts where there are no marked clones at all. To obtain the induction frequency for clones that contain at least one marked cell we have to divide ( ) by the probability that a heart is unlabeled in a given color, 1 − (0). Therefore, when restricting attention to labeled hearts, the probability of induction events is given by
Consequently, we obtain for the mean number of induced cells in labeled hearts
which, in the present case, is approximately equal to 1.8.
With this estimate for
, we may now turn to consider the probability distribution of fragment numbers, ( ), and the estimate of the degree of fragmentation, . By fixing the value of we can restrict the possible parameters to a slice through the ----plane ( Supplementary Fig. S3a and b) . Making use of the formula for ( ), analysis of the maximum likelihood shows that = 1.6 ± 0.2. Both, the induction frequency and the degree of fragmentation are in agreement with the values obtained above.
As a further consistency check, we may note that, with these values of and f, the average number of fragments labeled hearts, !"#$!$% , is given by 4.6, which compares excellently with the experimentally measured value of 4.7. Indeed, with the fitted values, the predicted fragment number distribution compares favorably with the measured distribution, as indicated in Fig. 3e .
Note that, to estimate , we made use of the fact that the induction frequency is roughly equal for all fluorescent markers for bicolor and tricolor hearts. However, for unicolor hearts, the frequencies of the different colors are manifestly different. If the statistical weights of the different colors in unicolor hearts were representative for all hearts, this might lead one to conclude that induction frequencies are also different for multicolor hearts. Since the degree of fragmentation should not depend on the color of fluorescent label, we may analyze the total fragment numbers, !"#$!$% , to test whether or not the overall induction frequency does indeed depend on the color of the fluorescent marker. If unicolor hearts were representative for all hearts, one would expect that !"#$!$% depends sensitively on the induced color. Taking all labeled hearts (uni--, bi--and tricolor), we find that the average number of fragments is 4.6 ± 0.3, 4.1 ± 0.4 and 5.4 ± 0.3 for YFP (n=87), CFP (n=83) and RFP (n=92), respectively, which suggests that the induction frequency is only weakly dependent on the color of the fluorescent marker. We attribute the apparently non--representative induction of unicolor hearts to a thresholding effect in which the sensitivity of different colors to induction is amplified when the level of Cre expression is low.
Mesp1 positive cells are restricted to either the first or the second heart field
With the value of the induction frequency and degree of fragmentation fixed, we may now make an informed decision on which hearts are monoclonal. To begin, we note that the probability that patches derive from clones is given by
Therefore, the probability that fragments are of clonal origin is given by
. Similarly, the probability that patches derive from more than one clone is obtained by summing over all induction outcomes larger than one,
To make a decision on the maximum number of fragments we consider to be of clonal origin, we compare these two: we consider fragments to be monoclonal if the probability that that they stem from a single cell, ( = 1| ), is larger than the probability that they stem from more than one cell, ( > 1| ). Specifically, in the spirit of the theory of Bayesian inference, we compute the logarithm of these two probabilities and multiply by --2,
With this definition, fragments are considered monoclonal if > 0. Taking the values for and obtained in the previous section, we find that 3 or less fragments of a single color are likely monoclonal, cf. Fig. 3 g and h. Indeed, with this classification, we expect that some 12% of hearts designated as monoclonal would in fact be polyclonal.
How does the approximation of equal induction frequencies in bicolor hearts affect this threshold value? If the type of fluorescent protein does not influence the degree of fragmentation, this would mean that the likelihood that a given number of patches is monoclonal is higher for CFP than for the other fluorescent markers in bicolor hearts. In other words, treating the induction frequency separately would allow us to treat some bicolor hearts as monoclonal, which have slightly more than 3 patches. Hence, treating the induction frequencies of different colors separately only marginally increases the sample size of monoclonal hearts.
With these results we may now restrict our analysis to hearts, in which a single clone has been labeled per color. Remarkably, we find that, of the 89 cases of hearts that are deemed to have marked fragments of clonal origin in either the FHF (LV) or the SHF (OFT and IFT), all are restricted to one or the other heart field. None of these clones contribute to both heart fields. (We note that this apparently perfect segregation of clones is further assisted by the histogenesis which, as we will see below, leads to the temporal separation in the specification of progenitors of the two heart fields.) By contrast, of the 69 clones that have fragments in the FHF, 15% also have fragments in the other heart compartments (i.e. the RV and the RA). Similarly, of the 20 clones that have fragments in the SHF, 55% have fragments in other heart compartments. Figure.  3i shows the percentage of clones that contribute to the different heart compartments given that they contribute to the FHF (left) or SHF (right), respectively. We conclude that, by the time of induction, Mesp1+ cells are already lineage restricted, contributing to either the first or second heart field, but not both. However, both Mesp1+ subpopulations are able to contribute to cells in the remaining heart compartments.
To further scrutinize the properties of Mesp1+ cells we calculated the non conditional probabilities with which these cells contribute fragments to the different heart compartments ( Supplementary Fig. 5c ). For example, we find that about 10% of the fragments of FHF precursors end up in other compartments. This means, as 85% of FHF precursors exclusively contribute to the FHF, that from the remaining 15% approximately two out three fragments end up in other heart compartments.
These clones have an average number of fragments of ! = 2.10 ± 0.01 and ! = 2.60 ± 0.02 for FHF and SHF precursors, respectively. Taking into account the fact that, by introducing a threshold of = 3, we neglect clones with a large number of fragments (i.e. those lying in the tail of ( = 1| )), this result agrees well with the predicted value for the overall population, viz. + 1 = 2.6. This also tells us that fragmentation of SHF precursors is slightly higher than fragmentation of FHF precursors, which raises the question of whether the former might migrate more.
As a consistency check we may estimate the induction frequency and the degree of fragmentation of the two types of precursors independently by following the steps from the previous section. Since most of the contributions of these cells go into the FHF (LV) and the SHF (OFT and IFT), respectively, we restrict our analysis to fragments in these compartments. For the FHF precursors we find that = 1.07 ± 0.07 and = 0.78 ± 0.17 for FHF precursors and = 0.39 ± 0.16 and = 1.00 ± 0.22 for SHF precursors (the values for are shown in Supplementary  Fig.  S3d ). On the one hand, these results are in agreement with a higher degree of fragmentation of SHF precursors. On the other hand, this tells us that the induction frequency is significantly higher for FHF precursors. Moreover, noting that, as the overall induction frequency is the sum of the individual induction frequencies, the individual values for are in good agreement with the values obtained for the whole population of Mesp1 expressing cells. The fragmentation rates are, expectedly, lower, as we neglected fragments located in heart compartments other than the LV, OFT and IFT.
With the probability of single clones to contribute to the different heart compartments defined, we may now predict the overall distribution of fragments in all hearts. To this end, we may account for the neglect of large monoclonal clusters by calculating the effective degree of fragmentation of the two subpopulations as follows: !,! = 2 !,! /( ! + ! ) • ( + 1). In other words, we use the monoclonal data to infer the relative deviation of each subpopulation from the average number of fragments of a single clone, + 1, in the overall population. From this we obtain an estimate for the fragmentation rates of each subpopulation, viz. ! = 1.4 ± 0.2 and ! = 1.9 ± 0.3 ( Supplementary Fig. S3d ). Since the 95% confidence interval of the difference between these two values does not contain 0, this difference in fragmentation rates is statistically significant. With this result, we are then able to predict the experimentally observed distribution of fragments in all hearts with remarkable accuracy, cf. Supplementary Fig. S3e . One notable exception is the number of fragments in the RV, which is twice as large as that expected. We attribute this apparent discrepancy to the fact that there are clones that exclusively contribute to the RV. These are not included in the analysis of the monoclonal hearts, but they do, of course, contribute to the overall distribution of fragments.
Temporal induction of the FHF and SHF progenitors
To investigate the temporal order of fate specification we now take into account the time point of Dox administration. First, we address the proportion of FHF and SHF precursors that are labeled at each induction time. From the previous results, we know that FHF and SHF precursors are mutually exclusive with respect to their contributions to the LV (FHF) on the one hand and the OFT and IFT (SHF) on the other. As the labeling of clones can be considered statistically independent, the average number of induced FHF and SHF precursors is proportional to the average number of fragments in these compartments Then, since the probability !,! ( ) of a single Mesp1 expressing cell to be induced should not depend on the particular time point of induction, we can make the simplification
Therefore, the ratio represents the proportion of FHF and SHF derivatives that are induced at time . Importantly, this proportion can be estimated by analyzing the total numbers of fragments in all hearts. From this analysis, we find that most FHF derivatives are induced at induction times E6.25 and E6.75 (89%) while most SHF derivatives are labeled at induction times E6.75 and E7.25 (95%), cf. Fig. 3k .
Finally, one may also use the analysis of data from the monoclonal fragments alone as a consistency check. Here, the number of induced clones, ! and ! ( ) are directly accessible. In agreement with the results incorporating all hearts we find that FHF precursors are mostly induced early (E6.25 and E6.75) and SHF progenitors are mostly induced late (E7.25). However, in contrast to the results obtained from the full data set, none or very few of the SHF precursors are induced at E6.75. We attribute this to the fact that, at this time point, Mesp1 is only expressed at low levels in SHF precursors. As a result, these cells will
